{
    "title": "2020",
    "abstract": "2020 Erin L. Schenk Tejas Patil Jose Pacheco Paul A. Bunn Implications for Practice Lung cancer survival rates have improved because of new prevention, screening, and therapy methods. This work provides a review of current standards for each of these areas, including targeted and immunotherapies. Treatment recommendations are provided for all stages of lung cancer.",
    "authors": [
        "Erin L. Schenk",
        "Tejas Patil",
        "Jose Pacheco",
        "Paul A. Bunn"
    ],
    "published_year": "2020",
    "description": "Implications for Practice\n          Lung cancer survival rates have improved because of new prevention, screening, and therapy methods. This work provides a review of current standards for each of these areas, including targeted and immunotherapies. Treatment recommendations are provided for all stages of lung cancer.",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930417/",
    "doi": "https://doi.org/10.1002/onco.13590"
}